Sustained-release procainamide and neutropenia.
D000380:Agranulocytosis / Q000139:chemically induced*; D003692:Delayed-Action Preparations; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced*; D011342:Procainamide / Q000009:adverse effects*
D003692:Delayed-Action Preparations; D011342:Procainamide